Female sexual dysfunction: therapeutic options and experimental challenges

Area of Science:

• Reproductive Medicine and Urology
• Women's Health
• Gerontology

Background:

• Female sexual dysfunction (FSD) is a widespread condition affecting approximately 40% of women, often increasing with age.
• Symptoms include reduced lubrication, dyspareunia, decreased arousal, and difficulty with orgasm, yet few women seek medical help.
• Research and treatment for FSD lag significantly behind male erectile dysfunction, with psychological therapy being the primary intervention.

Purpose of the Study:

• To provide an up-to-date overview of the current knowledge on FSD.
• To highlight recent advances in basic science research related to FSD.
• To explore emerging therapeutic strategies for managing FSD.

Main Methods:

• This is a review article, synthesizing existing scientific literature.
• It draws upon findings from animal models to inform understanding of FSD.
• The review focuses on current knowledge and developing therapeutic options.

Main Results:

• FSD is linked to cardiovascular conditions such as atherosclerosis, peripheral arterial disease, and hypertension, mirroring associations seen in male erectile dysfunction.
• While animal models have advanced understanding, significant knowledge gaps remain for effective human treatment.
• Current therapeutic options for FSD are limited, primarily relying on psychological interventions.

Conclusions:

• There is a critical need for further research into the pathophysiology of FSD to develop effective treatments.
• Exploring novel therapeutic avenues beyond psychological therapy is essential.
• Addressing FSD requires a comprehensive approach, considering its links to aging and cardiovascular health.